Oral contraceptives and survival in breast cancer patients aged 20 to 54 years. 2007

Katrina F Trivers, and Marilie D Gammon, and Page E Abrahamson, and Mary Jo Lund, and Elaine W Flagg, and Patricia G Moorman, and Jay S Kaufman, and Jianwen Cai, and Peggy L Porter, and Louise A Brinton, and J William Eley, and Ralph J Coates
Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, 4770 Buford Highway, NE, MS K-52, Atlanta, GA 30341, USA. ktrivers@cdc.gov

Recent oral contraceptive (OC) use is associated with modestly higher breast cancer incidence among younger women, but its impact on survival is unclear. This study examined the relationship between OC use before breast cancer diagnosis and survival. A population-based sample of 1,264 women aged 20 to 54 years with a first primary invasive breast cancer during 1990 to 1992 were followed up for 8 to 10 years. OC and covariate data were obtained by interviews conducted shortly after diagnosis and from medial records. All-cause mortality was ascertained through the National Death Index (n = 292 deaths). Age- and income-adjusted hazard ratios (HR) and 95% confidence intervals (95% CI) were estimated by Cox regression methods. All-cause mortality was not associated with ever use of OCs or duration of use. Compared with nonusers, mortality estimates were elevated among women who were using OCs at diagnosis or stopped use in the previous year (HR, 1.57; 95% CI, 0.95-2.61). The HR for use of high-dose estrogen pills within 5 years before diagnosis was double that of nonusers (HR, 2.39; 95% CI, 1.29-4.41) or, if the most recent pill included the progestin levonorgestrel, compared with nonusers (HR, 2.01; 95% CI, 1.03-3.91). Because subgroup estimates were based on small numbers of OC users, these results should be cautiously interpreted. Overall, most aspects of OC use did not seem to influence survival, although there is limited evidence that OC use just before diagnosis, particularly use of some pill types, may negatively impact survival in breast cancer patients aged 20 to 54 years.

UI MeSH Term Description Entries
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D003276 Contraceptives, Oral Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both. Low-Dose Oral Contraceptive,Oral Contraceptive,Oral Contraceptives,Oral Contraceptives, Low-Dose,Oral Contraceptives, Phasic,Contraceptive, Low-Dose Oral,Contraceptive, Oral,Contraceptives, Low-Dose Oral,Contraceptives, Phasic Oral,Low Dose Oral Contraceptive,Low-Dose Oral Contraceptives,Oral Contraceptive, Low-Dose,Oral Contraceptives, Low Dose,Phasic Oral Contraceptives
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age

Related Publications

Katrina F Trivers, and Marilie D Gammon, and Page E Abrahamson, and Mary Jo Lund, and Elaine W Flagg, and Patricia G Moorman, and Jay S Kaufman, and Jianwen Cai, and Peggy L Porter, and Louise A Brinton, and J William Eley, and Ralph J Coates
September 1994, Lancet (London, England),
Katrina F Trivers, and Marilie D Gammon, and Page E Abrahamson, and Mary Jo Lund, and Elaine W Flagg, and Patricia G Moorman, and Jay S Kaufman, and Jianwen Cai, and Peggy L Porter, and Louise A Brinton, and J William Eley, and Ralph J Coates
January 2000, Journal of the National Cancer Institute,
Katrina F Trivers, and Marilie D Gammon, and Page E Abrahamson, and Mary Jo Lund, and Elaine W Flagg, and Patricia G Moorman, and Jay S Kaufman, and Jianwen Cai, and Peggy L Porter, and Louise A Brinton, and J William Eley, and Ralph J Coates
January 1988, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Katrina F Trivers, and Marilie D Gammon, and Page E Abrahamson, and Mary Jo Lund, and Elaine W Flagg, and Patricia G Moorman, and Jay S Kaufman, and Jianwen Cai, and Peggy L Porter, and Louise A Brinton, and J William Eley, and Ralph J Coates
September 1987, British journal of cancer,
Katrina F Trivers, and Marilie D Gammon, and Page E Abrahamson, and Mary Jo Lund, and Elaine W Flagg, and Patricia G Moorman, and Jay S Kaufman, and Jianwen Cai, and Peggy L Porter, and Louise A Brinton, and J William Eley, and Ralph J Coates
December 2002, International journal of clinical practice,
Katrina F Trivers, and Marilie D Gammon, and Page E Abrahamson, and Mary Jo Lund, and Elaine W Flagg, and Patricia G Moorman, and Jay S Kaufman, and Jianwen Cai, and Peggy L Porter, and Louise A Brinton, and J William Eley, and Ralph J Coates
October 1994, Geburtshilfe und Frauenheilkunde,
Katrina F Trivers, and Marilie D Gammon, and Page E Abrahamson, and Mary Jo Lund, and Elaine W Flagg, and Patricia G Moorman, and Jay S Kaufman, and Jianwen Cai, and Peggy L Porter, and Louise A Brinton, and J William Eley, and Ralph J Coates
September 1985, Journal of surgical oncology,
Katrina F Trivers, and Marilie D Gammon, and Page E Abrahamson, and Mary Jo Lund, and Elaine W Flagg, and Patricia G Moorman, and Jay S Kaufman, and Jianwen Cai, and Peggy L Porter, and Louise A Brinton, and J William Eley, and Ralph J Coates
August 1995, International journal of cancer,
Katrina F Trivers, and Marilie D Gammon, and Page E Abrahamson, and Mary Jo Lund, and Elaine W Flagg, and Patricia G Moorman, and Jay S Kaufman, and Jianwen Cai, and Peggy L Porter, and Louise A Brinton, and J William Eley, and Ralph J Coates
February 2001, Mayo Clinic women's healthsource,
Katrina F Trivers, and Marilie D Gammon, and Page E Abrahamson, and Mary Jo Lund, and Elaine W Flagg, and Patricia G Moorman, and Jay S Kaufman, and Jianwen Cai, and Peggy L Porter, and Louise A Brinton, and J William Eley, and Ralph J Coates
August 2017, JAMA,
Copied contents to your clipboard!